Literature DB >> 20439090

Burden of chronic kidney disease: an international perspective.

Olugbenga E Ayodele1, C Olutayo Alebiosu.   

Abstract

CKD is associated with increased cardiovascular mortality and a loss of disability-adjusted life years. Diseases of the genitourinary system were responsible for 928,000 deaths and 14,754,000 disability-adjusted life years in 2004. However, the absence of kidney registries in most of the low- and middle-income countries has made it difficult to ascertain the true burden of CKD in these countries. The global increase in the incidence and prevalence of CKD is being driven by the global increase in the prevalence of diabetes mellitus, hypertension, obesity, and aging. Most patients in low- and middle-income countries die because they cannot access renal replacement therapy because of the exorbitant cost. Community surveys have shown that the number of people with end-stage kidney disease is just the tip of the "CKD iceberg." The preventive strategies to stem the tide of CKD should involve educating the population on how to prevent renal disease; identifying those at risk of developing CKD; raising the awareness of the general public, policy makers, and health care workers; modifying the lifestyle of susceptible individuals; detecting early stage of CKD; arresting or hindering the progression of disease; and creating facilities for global assistance. Copyright 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20439090     DOI: 10.1053/j.ackd.2010.02.001

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  42 in total

1.  Nicaragua revisited: evidence of lower prevalence of chronic kidney disease in a high-altitude, coffee-growing village.

Authors:  Timothy S Laux; Philip J Bert; Gerardo M Barreto Ruiz; Marvin González; Mark Unruh; Aurora Aragon; Cecilia Torres Lacourt
Journal:  J Nephrol       Date:  2012 Jul-Aug       Impact factor: 3.902

2.  Risk factors associated with disease progression and mortality in chronic kidney disease of uncertain etiology: a cohort study in Medawachchiya, Sri Lanka.

Authors:  Lalantha Senevirathna; Tilak Abeysekera; Shanika Nanayakkara; Rohana Chandrajith; Neelakanthi Ratnatunga; Kouji H Harada; Toshiaki Hitomi; Toshiyuki Komiya; Eri Muso; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2011-09-01       Impact factor: 3.674

Review 3.  Access to medications and conducting clinical trials in LMICs.

Authors:  Ikechi G Okpechi; Charles R Swanepoel; Francois Venter
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

4.  Visceral adiposity index, hypertriglyceridemic waist phenotype and chronic kidney disease in a southern Chinese population: a cross-sectional study.

Authors:  Jun Huang; Chaomin Zhou; Yongqiang Li; Shuangshuang Zhu; Aiqun Liu; Xiaofei Shao; Xinyu Liu; Harry Holthfer; Hequn Zou
Journal:  Int Urol Nephrol       Date:  2015-07-07       Impact factor: 2.370

5.  Evaluation of the impact of pharmaceutical care service on hospitalized patients with chronic kidney disease in Jordan.

Authors:  Salah M AbuRuz; Yazan Alrashdan; Anan Jarab; Deema Jaber; Izzat A Alawwa
Journal:  Int J Clin Pharm       Date:  2013-07-25

Review 6.  Early chronic kidney disease: diagnosis, management and models of care.

Authors:  Olivier J Wouters; Donal J O'Donoghue; James Ritchie; Panos G Kanavos; Andrew S Narva
Journal:  Nat Rev Nephrol       Date:  2015-06-09       Impact factor: 28.314

7.  Urinary Fibrinogen as a Predictor of Progression of CKD.

Authors:  Hongtian Wang; Chunxia Zheng; Yinghui Lu; Qi Jiang; Ru Yin; Ping Zhu; Minlin Zhou; Zhihong Liu
Journal:  Clin J Am Soc Nephrol       Date:  2017-09-13       Impact factor: 8.237

8.  Therapeutic potential of different commercially available synbiotic on acetaminophen-induced uremic rats.

Authors:  Arpita Mandal; Arpita Patra; Shreya Mandal; Suchismita Roy; Shreya Das Mahapatra; Tapasi Das Mahapatra; Tanmay Paul; Koushik Das; Keshab Chandra Mondal; Dilip Kumar Nandi
Journal:  Clin Exp Nephrol       Date:  2014-04-17       Impact factor: 2.801

Review 9.  Cholesterol Metabolism in CKD.

Authors:  Allison B Reiss; Iryna Voloshyna; Joshua De Leon; Nobuyuki Miyawaki; Joseph Mattana
Journal:  Am J Kidney Dis       Date:  2015-09-01       Impact factor: 8.860

10.  Association of reduced renal function with hepatitis B virus infection and elevated alanine aminotransferase.

Authors:  Jianfang Cai; Xiaohong Fan; Lijun Mou; Bixia Gao; Xuejiao Liu; Jinhong Li; Lili Liu; Haiyun Wang; Zengyu Guo; Xiaoqing Liu; Hang Li; Xuemei Li; Xuewang Li
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-02       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.